In ten studies, it was found on a statistically significant level that BRAF mutant tumors were more likely to develop PM and/or that patients with PM had more often BRAF mutated primary tumors compared to PM-free CRC patients [22,27,33,34,39,40,45,46,48,49]. The gene discussed is BRAF; the disease is colorectal carcinoma.